Little Green Pharma Ltd. announced the appointment of Ms. Beatriz Vicén Banzo as non-executive director, effective July 7, 2022. With a decorated career as an expert in regulatory affairs for European pharmaceutical companies, Ms. Vicén Banzo joins LGP having served as Director of Public Affairs and Quality for Bayer in Spain ­ the Spanish division of the global pharmaceutical leader ­ since August 2011. In her senior position at Bayer Pharmaceuticals in Spain, she has been responsible for quality assurance, regulatory affairs, pricing and market access across the business's divisions, which consist of pharmaceuticals, consumer health, and radiology and intervention.

Prior to working at Bayer Ms. Vicén Banzo held the position of Head of Regulatory Affairs and Permanent Executive Committee Guest at global healthcare company Novartis Pharmaceutical Company for almost a decade, and prior to that held the position of Regulatory Affairs Expert at Ciba-Geigy, a large Swiss-based pharmaceutical and chemicals group that merged with Sandoz to become Novartis. Ms. Vicén Banzo holds a Degree in Pharmacy as well as an MBA from the University of Barcelona. She also possesses a Master in European Regulatory Procedures from the Autonomous University of Barcelona as well as an additional MBA from the globally renowned ESADE Business School.

She has been a lecturer for the Masters program at Madrid-based Professional College Talento Farmacéutico since 2015 and is fluent in four languages. The appointment coincides with LGP's expansion of its operations throughout Europe, following its acquisition and integration of a large manufacturing facility based in Denmark in 2021.